These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2446823)

  • 1. Corneal neovascularization. Pathogenesis and inhibition.
    Epstein RJ; Stulting RD; Hendricks RL; Harris DM
    Cornea; 1987; 6(4):250-7. PubMed ID: 2446823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corneal neovascularization induced by stimulated lymphocytes in inbred mice.
    Epstein RJ; Stulting RD
    Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1505-13. PubMed ID: 2442116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy for corneal neovascularization.
    Epstein RJ; Hendricks RL; Harris DM
    Cornea; 1991 Sep; 10(5):424-32. PubMed ID: 1834434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-2 induces corneal neovascularization in A/J mice.
    Epstein RJ; Hendricks RL; Stulting RD
    Cornea; 1990 Oct; 9(4):318-23. PubMed ID: 1706652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Animal experiment studies on the role of inflammation mediators in corneal neovascularization].
    Rochels R
    Doc Ophthalmol; 1984 May; 57(3):215-62. PubMed ID: 6205837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corneal neovascularization: updates on pathophysiology, investigations & management.
    Sharif Z; Sharif W
    Rom J Ophthalmol; 2019; 63(1):15-22. PubMed ID: 31198893
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanisms of corneal neovascularization and modern options for its suppression].
    Mamikonyan VR; Pivin EA; Krakhmaleva DA
    Vestn Oftalmol; 2016; 132(4):81-87. PubMed ID: 28635927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous but not prior inhibition of VEGF165 enhances the efficacy of photodynamic therapy in multiple models of ocular neovascularization.
    Ju M; Mailhos C; Bradley J; Dowie T; Ganley M; Cook G; Calias P; Lange N; Adamis AP; Shima DT; Robinson GS
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):662-70. PubMed ID: 18235012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Corneal Neovascularization and Its Impact on Visual Acuity and Sensitivity: A 14-Year Retrospective Study.
    Lasagni Vitar RM; Triolo G; Fonteyne P; Acuti Martellucci C; Manzoli L; Rama P; Ferrari G
    Front Med (Lausanne); 2021; 8():733538. PubMed ID: 34722575
    [No Abstract]   [Full Text] [Related]  

  • 10. Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis.
    Bachmann B; Taylor RS; Cursiefen C
    Ophthalmology; 2010 Jul; 117(7):1300-5.e7. PubMed ID: 20605214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal neovascularization after penetrating keratoplasty.
    Dana MR; Schaumberg DA; Kowal VO; Goren MB; Rapuano CJ; Laibson PR; Cohen EJ
    Cornea; 1995 Nov; 14(6):604-9. PubMed ID: 8575183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent herpes simplex keratitis after verteporfin photodynamic therapy for corneal neovascularization.
    Yoon KC; Im SK; Park HY
    Cornea; 2010 Apr; 29(4):465-7. PubMed ID: 20164757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization.
    Holzer MP; Solomon KD; Vroman DT; Sandoval HP; Margaron P; Kasper TJ; Crosson CE
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2954-8. PubMed ID: 12824237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-8. A corneal factor that induces neovascularization.
    Strieter RM; Kunkel SL; Elner VM; Martonyi CL; Koch AE; Polverini PJ; Elner SG
    Am J Pathol; 1992 Dec; 141(6):1279-84. PubMed ID: 1281615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness).
    Pearlman E; Lass JH; Bardenstein DS; Kopf M; Hazlett FE; Diaconu E; Kazura JW
    J Exp Med; 1995 Oct; 182(4):931-40. PubMed ID: 7561696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal argon laser photocoagulation for neovascularization in penetrating keratoplasty.
    Nirankari VS; Baer JC
    Ophthalmology; 1986 Oct; 93(10):1304-9. PubMed ID: 2431371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argon laser photodynamic therapy of human corneal neovascularization after intravenous administration of dihematoporphyrin ether.
    Sheppard JD; Epstein RJ; Lattanzio FA; Marcantonio D; Williams PB
    Am J Ophthalmol; 2006 Mar; 141(3):524-529. PubMed ID: 16490500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related changes in murine limbal lymphatic vessels and corneal lymphangiogenesis.
    Hos D; Bachmann B; Bock F; Onderka J; Cursiefen C
    Exp Eye Res; 2008 Nov; 87(5):427-32. PubMed ID: 18755186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent drug therapies for corneal neovascularization.
    Liu X; Wang S; Wang X; Liang J; Zhang Y
    Chem Biol Drug Des; 2017 Nov; 90(5):653-664. PubMed ID: 28489275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkali-induced corneal neovascularization is independent of CXCR2-mediated neutrophil infiltration.
    Lu P; Li L; Mukaida N; Zhang X
    Cornea; 2007 Feb; 26(2):199-206. PubMed ID: 17251813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.